Antibody Engineering

Theresa M. Allen, Ph.D., University of Alberta; Center for Drug Research & Development (CDRD), Canada

Carlos F. Barbas III, Ph.D., The Scripps Research Institute

Amrik Basran, Ph.D., GlaxoSmithKline, United Kingdom

Helen Baxendale, MBBS, Ph.D., Royal Free Hospital and University College Medical School, United Kingdom

Richard H.J. Begent, M.D., University College London, United Kingdom

Andrew Bradbury, M.B., B.S., Ph.D., Los Alamos National Laboratories; The Antibody Society

Felix Breden, Ph.D., Simon Fraser University, Canada

Dennis R. Burton, Ph.D., The Scripps Research Institute

Kerry A. Chester, Ph.D., University College London, United Kingdom

Raphael Clynes, M.D., Ph.D., Columbia University

Melvin Cohn, Ph.D., Salk Institute

James E. Crowe, Jr., M.D., Vanderbilt Medical Center

Henry F. Edelhauser, Ph.D., Emory University Eye Center

Damian C. Ekiert, The Scripps Research Institute

Georg H. Fey, Ph.D., University of Erlangen, Germany

David J. FitzGerald, Ph.D., National Cancer Institute

Germaine Fuh, Ph.D., Genentech, Inc.

Dai Fukumura, M.D., Ph.D., Massachusetts General Hospital and Harvard Medical School

Tariq Ghayur, Ph.D., Abbott Bioresearch Center

Gottfried Himmler, Ph.D., f-star Biotechnology, Austria

James S. Huston, Ph.D., EMD Serono Research Center

E. Yvonne Jones, Ph.D., Oxford University, United Kingdom

Debbie Law, Ph.D., Ablynx, Belgium

Marie-Paule Lefranc, Ph.D., CNRS Institute of Human Genetics, IMGT, France

Ravindra Majeti M.D., Ph.D., Stanford University

Wayne A. Marasco, M.D., Ph.D., Harvard Medical School

James D. Marks M.D., Ph.D., University of California, San Francisco

Shuming Nie, Ph.D., Emory University; Georgia Institute of Technology

Ulrik Nielsen, Ph.D., Merrimack Pharmaceuticals

Michel Nussenzweig M.D., Ph.D., Howard Hughes Medical Institute, The Rockefeller University

Kevin C. O'Connor, Ph.D., Harvard Medical School

Mats Ohlin, Ph.D., Lund University, Sweden

Andreas Plueckthun, Ph.D., University of Zuerich, Switzerland

Anthony R. Rees, Ph.D., MIP Technologies AB, Sweden

Dinakar M. Salunke, Ph.D., National Institute of Immunology, India

Jan E. Schnitzer, M.D., Sidney Kimmel Cancer Center

Andrew Scott, M.D., Ludwig Institute for Cancer Research, Australia

Jamie K. Scott, M.D., Ph.D., Simon Fraser University, Canada

David M. Segal, Ph.D., National Institutes of Health

Michael Sierks, Ph.D., Arizona State University

Arne Skerra, Ph.D., Pieris AG; Technical University of Munich, Germany

Vaughn Smider, M.D., Ph.D., Fabrus, LLC; The Scripps Research Institute

Paul M. Sondel, M.D., Ph.D., University of Wisconsin

Jamshid Temirov, Ph.D., Life Technologies

Philip E. Thorpe, Ph.D., University of Texas Southwestern Medical Center

Ian M. Tomlinson, Ph.D., GlaxoSmithKline, United Kingdom

David Urech, Ph.D., ESBATech, Switzerland

E. Sally Ward, Ph.D., University of Texas Southwestern Medical Center

Howard L. Weiner, M.D., Brigham and Women's Hospital

Louis M. Weiner, M.D., Georgetown University Medical Center

Patrick C. Wilson, Ph.D., The University of Chicago

Jan van de Winkel, Ph.D., Genmab, The Netherlands

K. Dane Wittrup, Ph.D., Adimab, Inc.; Massachusetts Institute of Technology

Wei Yan, Ph.D., Amgen Inc.

Antibody Therapeutics

Mark R. Alfenito, Ph.D., KaloBios Pharmaceuticals Inc.

Laura Andrews, Ph.D., DABT, Genzyme Corporation

Patrick A. Baeuerle, Ph.D., Micromet AG, Germany

David Blakey, Ph.D., AstraZeneca, United Kingdom

Soren Bregenholt, Ph.D., Symphogen A/S, Denmark

Rolf A. Brekken, Ph.D., University of Texas Southwestern Medical Center

Christopher C. Broder, Ph.D., Uniformed Services University

Benjamin P. Chen, Ph.D., Burrill & Company

Anthony J. Coyle, Ph.D., MedImmune, Inc.

Rathin C. Das, Ph.D., Affitech AS & Affitech USA, Inc.

John R. Desjarlais, Ph.D., Xencor, Inc.

Ron Eastman, Essex Woodlands Health Ventures

Tillman U. Gerngross, Ph.D., Adimab

Jason Kantor, Ph.D., RBC Capital Markets

Patrick Kelly, M.D., Wyeth Research

Andrew Kumamoto, Ph.D., McDermott, Will & Emery

William A. Kuziel, Ph.D., Daiichi Sankyo Research Institute

Peter Lichtlen, M.D., Ph.D., ESBATech, Switzerland

Nils Lonberg, Ph.D., Medarex Inc.

Teresa Parli, M.D., KaloBios Pharmaceuticals Inc.

Paul W.H.I. Parren, Ph.D., Genmab, The Netherlands

Martyn Robinson, Ph.D., UCB, United Kingdom

Anil Singhal, Ph.D., Facet Biotech

Michael Steward, Ph.D., GlaxoSmithKline, United Kingdom

Trudi Veldman, Ph.D., Abbott Laboratories

Kirsten Voelp, Ph.D., Biotest AG, Germany

Philip Webber, Ph.D., Frank B. Dehn & Co, United Kingdom

Nancy C. Whiting, PharmD, BCOP Seattle Genetics, Inc.

David S. Wilson, Ph.D., Arana Therapeutics Ltd.

Yan Wu, M.D., ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company

Michael Yellin, M.D., Medarex, Inc.